RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TREZZI M
Collezione ASL Città di Torino

Items : 5

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine. in Infection / Infection. 2024 Jun;52(3):737-765. doi: 10.1007/s15010-024-02183-3. Epub 2024 Feb 8.

2024
ASL Città di Torino

Palmieri F; Gori A; Falbo E; Mencarini J; Surace L; Pontali E; Gualano G; Russo A; Pirriatore V; Trezzi M; Di Biagio A; Riccardi N; Parrella R; Matteelli A; Tadolini M; Sarmati L; Coppola N; Calcagno A; Schiuma M; Lapadula G; Goletti D;

18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.

2023
ASL Asti
ASL Città di Torino

Aliberti S; Calcagno A; Di Perri G; Lupia T; Sestini S; Erba PA; Betti M; Botto C; Trezzi M; Venuti F; Penna D; Piccioni P; Gaviraghi A; Stroffolini G;

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey. in The new microbiologica / New Microbiol. 2022 Dec;45(4):260-268. Epub 2022 Oct 3.

2022
ASL Città di Torino

Riccardi N; Antonello RM; Giacomelli A; Saderi L; Canetti D; Pallotto C; Mazzaferri F; Degli Antoni AM; Cardellino C; Motta I; Calcagno A; Falcone M; Trezzi M; Comelli A; Pascale R; Merli M; Binda F; Angheben A; Sotgiu G; Gobbi F; Nozza S;

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986.

2019
ASL Città di Torino

Rossetti B; Gagliardini R; Sterrantino G; Colangeli V; Latini A; Colafigli M; Vignale F; Rusconi S; Di Biagio A; Orofino G; Mezzaroma I; Vullo V; Francisci D; Mastroianni C; Trezzi M; Canovari B; Lamonica S; Ciccullo A; Borghetti A; D?Arminio Monforte A; Di Giambenedetto S; De Luca A;

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. in PloS one / PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2017
ASL Città di Torino

Rossetti B; Gagliardini R; Meini G; Sterrantino G; Colangeli V; Re MC; Latini A; Colafigli M; Vignale F; Rusconi S; Micheli V; Di Biagio A; Orofino G; Ghisetti V; Fantauzzi A; Vullo V; Grima P; Francisci D; Mastroianni C; Antinori A; Trezzi M; Lisi L; Navarra P; Canovari B; D'Arminio Monforte A; Lamonica S; D'Avino A; Zazzi M; Di Giambenedetto S; et alii...